Filtros de búsqueda

Lista de obras de

18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer

scientific article published on 20 July 2020

18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer

artículo científico publicado en 2014

A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy

artículo científico publicado en 2015

A Plea for Long-Term Surveillance in Bacillus Calmette-Guérin–Treated Non–Muscle-Invasive Bladder Cancer ⬇️

artículo científico publicado el 7 de diciembre de 2011

A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye.

artículo científico publicado en 2013

A new and highly prognostic system to discern T1 bladder cancer substage.

artículo científico publicado en 2011

A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation

artículo científico publicado en 2005

A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine

artículo científico publicado en 2005

A testosterone-producing Leydig cell tumor metastasis during hormonal treatment of prostate cancer

scientific article published on 14 April 2020

ASO Author Reflections: How to Detect Peritoneal Metastases of Urachal Carcinoma? The Value of Diagnostic Laparoscopy and Abdominal Cytology in Staging This Rare Malignancy

artículo científico publicado en 2020

Added Clinical Value of 18F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy

scientific article published in 2023

Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome ⬇️

artículo científico publicado el 10 de noviembre de 2010

An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors

artículo científico publicado en 2018

Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role of CDKN2A deletions in the FGFR3 pathway

artículo científico publicado en 2016

BCAN Think Tank session 1: Overview of risks for and causes of bladder cancer.

artículo científico publicado en 2010

Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy

scientific article published on 27 April 2016

Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies

artículo científico publicado en 2023

Bladder cancer: Low adherence to guidelines in non-muscle-invasive disease

artículo científico publicado en 2016

Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?

artículo científico publicado en 2012

Catheter-assisted 18F-FDG-PET/CT imaging of primary bladder cancer: a prospective study

artículo científico publicado en 2012

Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?

artículo científico publicado en 2015

Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine

artículo científico publicado en 2003

Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer

artículo científico publicado en 2012

Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma

artículo científico publicado en 2020

Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT.

artículo científico publicado en 2012

Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases

scientific article published on 06 November 2019

Concurrent radiotherapy and panitumumab after lymph node dissection and induction chemotherapy for invasive bladder cancer

artículo científico publicado en 2019

Considerations on the use of urine markers for bladder cancer

scientific article published on 22 January 2008

Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.

artículo científico publicado en 2014

Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer

artículo científico

Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trial.

artículo científico publicado en 2010

Cytology and Urinary Markers for the Diagnosis of Bladder Cancer

Diagnostic Laparoscopy and Abdominal Cytology Reliably Detect Peritoneal Metastases in Patients with Urachal Adenocarcinoma

artículo científico publicado en 2020

Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma

artículo científico publicado en 2019

Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non-muscle-invasive Bladder Cancer: Results of a European Survey.

artículo científico publicado en 2017

Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences

scientific article published on 20 March 2020

Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

scientific article published on 17 September 2018

Dose dense MVAC prior to radical cystectomy: a real-world experience

artículo científico publicado en 2017

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

scientific article published on 17 June 2016

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

artículo científico

ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy

artículo científico publicado en 2015

Editorial comment

artículo científico publicado en 2011

Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer

artículo científico publicado en 2016

Endo-Urological Techniques for Benign Uretero-Ileal Strictures Have Poor Efficacy and Affect Renal Function

scientific article published on 18 August 2017

Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer

scientific article published on 03 February 2017

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

artículo científico publicado en 2021

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

scientific article published on 20 August 2019

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.

artículo científico publicado en 2017

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

artículo científico publicado en 2020

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

artículo científico

European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update ⬇️

artículo científico publicado el 19 de marzo de 2013

FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer

artículo científico publicado en 2012

FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†

artículo científico publicado en 2020

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma

artículo científico publicado en 2004

FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer.

artículo científico publicado en 2014

FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.

artículo científico publicado en 2010

Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation with Pten loss in mice

artículo científico publicado en 2014

Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1?

artículo científico publicado en 2015

Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations

artículo científico publicado en 2016

FrequentFGFR3mutations in urothelial papilloma

article

Genetics and biological markers in urachal cancer

artículo científico publicado en 2016

Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016".

artículo científico publicado en 2018

Hospital-specific probability of cystectomy affects survival from muscle-invasive bladder cancer

scientific article published on 08 September 2020

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers

artículo científico

Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle

artículo científico publicado en 2013

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

artículo científico publicado en 2017

Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer

artículo científico publicado en 2020

Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy

artículo científico publicado en 2016

Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?

scientific article published on 27 July 2018

Induction chemotherapy followed by surgery in node positive bladder cancer

artículo científico publicado en 2013

Intravesical recurrence after bladder sparing treatment of small cell carcinoma of the bladder: Characteristics, treatment, and outcome

artículo científico publicado en 2018

Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis

artículo científico publicado en 2017

Landmarks in non-muscle-invasive bladder cancer

artículo científico publicado en 2014

Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder ⬇️

artículo científico publicado el 11 de diciembre de 2012

Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis

artículo científico publicado en 2019

Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment

artículo científico publicado en 2010

Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin ⬇️

artículo científico publicado el 1 de septiembre de 2011

Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancer

scientific article published on 01 April 2019

Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancer

scientific article published on 17 October 2019

Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study

artículo científico publicado en 2010

Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template

artículo científico publicado en 2015

Lymphatic drainage from renal tumors in vivo: a prospective sentinel node study using SPECT/CT imaging

artículo científico publicado en 2017

MP03-06 PROSPECTIVE STUDY ON FDG-PET/CT FOR ON-TREATMENT ASSESSMENT OF RESPONSE TO NEOADJUVANT OR INDUCTION CHEMOTHERAPY IN INVASIVE BLADDER CANCER

scientific article published in 2022

Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy

artículo científico publicado en 2018

Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer

artículo científico publicado en 2018

Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines

artículo científico publicado en 2016

Molecular Characterization of Neuroendocrine-like Bladder Cancer

artículo científico publicado en 2019

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

scientific article published on 09 June 2010

Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications

artículo científico publicado en 2014

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome

artículo científico publicado en 2003

Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus

artículo científico publicado en 2014

Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice

artículo científico publicado en 2014

Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

artículo científico publicado en 2019

Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer

artículo científico publicado en 2014

Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis

scientific article published on 05 November 2020

Neoadjuvant dose dense MVAC versus GC in patients with cT3-4aN0M0 bladder cancer treated with radical cystectomy

artículo científico publicado en 2018

Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin

artículo científico publicado en 2015

Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future

artículo científico publicado en 2017

Non-muscle-invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost-effective alternative?

artículo científico publicado en 2008

Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis

artículo científico publicado en 2019

Nonprimary pT1 Nonmuscle Invasive Bladder Cancer Treated With Bacillus Calmette-Guerin is Associated With Higher Risk of Progression Compared to Primary T1 Tumors

artículo científico publicado en 2010

Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders

artículo científico publicado en 2002

Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone

artículo científico publicado en 2014

Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.

artículo científico publicado en 2016

Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review

artículo científico publicado en 2017

Optical coherence tomography accurately identifies patients with penile (pre) malignant lesions: A single center prospective study

artículo científico publicado en 2015

Optimal timing of radical cystectomy in T1 high-grade bladder cancer ⬇️

artículo científico publicado el 1 de diciembre de 2010

Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?

artículo científico publicado en 2019

Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas

artículo científico publicado en 2018

Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.

artículo científico publicado en 2016

Pathological stage review is indicated in primary pT1 bladder cancer

artículo científico publicado en 2009

Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.

artículo científico publicado en 2012

Penile sparing surgery for penile cancer-does it affect survival?

artículo científico publicado en 2013

Perioperatieve behandelingen en radicale cystectomie voor blaaskanker. Een trendanalyse over 10.338 patiënten in Nederland

Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the Netherlands.

artículo científico publicado en 2015

Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.

artículo científico publicado en 2017

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial

artículo científico publicado en 2020

Prognosis of Muscle-Invasive Bladder Cancer: Difference between Primary and Progressive Tumours and Implications for Therapy

Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Pane

artículo científico publicado en 2017

Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients

artículo científico publicado en 2014

Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder

artículo científico

Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.

artículo científico publicado en 2012

Prospective Evaluation of FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder Cancer

scientific article published in 2023

Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity

artículo científico publicado en 2011

Prostate sparing cystectomy for bladder cancer: 20-year single center experience

artículo científico publicado en 2013

Prostate sparing cystectomy for bladder cancer: A two-center study

scientific article published on 08 June 2018

Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: a convenient alternative to 5-fluorouracil

artículo científico publicado en 2020

Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer

artículo científico publicado en 2019

Re: Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing Tides

artículo científico publicado en 2016

Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations

scientific article published on 23 August 2020

Recent developments in perioperative combination therapy in muscle-invasive bladder cancer

scientific article published in 2023

Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network

artículo científico publicado en 2018

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy

artículo científico publicado en 2009

Reply to Anna Orsola, Inés de Torres and Juan Morote’s Letter to the Editor re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012:61:378?

Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder C

article published in 2015

Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61

artículo científico publicado en 2016

Reply to Maximilian Burger, Wolfgang Otto, and Arndt Hartmann's Letter to the Editor re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61

Reply: To PMID 24468513.

artículo científico publicado en 2014

Reproducibility and Prognostic Performance of the 1973 and 2004 World Health Organization Classifications for Grade in Non-muscle-invasive Bladder Cancer: A Multicenter Study in 328 Bladder Tumors

artículo científico publicado en 2018

Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel

artículo científico publicado en 2018

Robot-assisted Laparoscopic Implantation of Brachytherapy Catheters in Bladder Cancer

artículo científico publicado en 2017

Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.

artículo científico publicado en 2018

Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer

artículo científico publicado en 2018

Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic Progression

artículo científico publicado en 2016

Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer.

artículo científico publicado en 2011

Sexual Satisfaction in Men Suffering From Erectile Dysfunction After Robot-Assisted Radical Prostatectomy for Prostate Cancer: An Observational Study

artículo científico publicado en 2020

Staging fluorodeoxyglucose positron emission tomography/computed tomography for muscle‐invasive bladder cancer: a nationwide population‐based study

scientific article published in 2023

Surveillance with microsatellite analysis of urine in bladder cancer patients treated by radiotherapy.

artículo científico publicado en 2003

The FGFR3 mutation is related to favorable pT1 bladder cancer.

artículo científico publicado en 2011

The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy

scientific article published in 2022

The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC)

artículo científico publicado en 2020

The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer

artículo científico publicado en 2018

The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic

artículo científico publicado en 2020

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder

scientific article published on 02 October 2020

The comprehensive complication index is associated with a significant increase in complication severity between 30 and 90 days after radical cystectomy for bladder cancer

artículo científico publicado en 2020

The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin

artículo científico publicado en 2015

The molecular background of urothelial cancer: ready for action?

artículo científico publicado en 2014

The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading

artículo científico publicado en 2009

The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy

scientific article published on 31 October 2019

Toward Optimal Prediction of Prognosis in T1 Urothelial Carcinoma of the Bladder.

artículo científico publicado en 2015

Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer

scientific article published on 16 March 2020

Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations

artículo científico publicado en 2018

Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.

artículo científico publicado en 2012

Urine markers for bladder cancer surveillance: a systematic review

artículo científico publicado en 2005

Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes

artículo científico publicado en 2018

Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer

artículo científico

Variation in Follow-Up after Radical Cystectomy for Bladder Cancer—An Inventory Roundtable and Literature Review

artículo científico publicado en 2024

WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach.

artículo científico publicado en 2016

Word of wisdom. Re: prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review

artículo científico

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda